Johnson & Johnson settles opioid case in New York, will pay up to $230 million and stop selling deadly drugs in US

Johnson & Johnson has agreed to cough up a settlement of up to $230 million and stop selling opioids in the US. The sum is a drop in the ocean for the firm, but comes as nationwide trials could see payouts in the billions.

“Johnson & Johnson will pay up to $230 million for its role in fueling the opioid crisis that has devastated communities across New York,” the state’s attorney general, Letitia James, announced on Saturday. The settlement excludes the drugmaker from an upcoming lawsuit charging multiple opioid manufacturers and distributors with deceptively marketing these addictive painkillers and downplaying the threat of addiction.

#BREAKING: Johnson & Johnson will pay up to $230 million for its role in fueling the opioid crisis that has devastated communities across New York.
As part of our unprecedented settlement, @JNJNews will also stop manufacturing or selling opioids nationwide.
— NY AG James (@NewYorkStateAG) June 26, 2021

https://www.rt.com/usa/527689-jj-settles-opioid-lawsuit/?utm_source=rss&utm_medium=rss&utm_campaign=RSS

Got a news tip or correction? Let us know

If you got something out of this, please chip in to keep this site running, or subscribe to go ad-free.

2 views